К основному контенту

Clomid

Clomid

     * Generic Name: clomiphene
     * Brand Name: Clomid


     * What is clomiphene (Clomid, Serophene)?
     * What are the possible side effects of clomiphene (Clomid,
       Serophene)?
     * What is the most important information I should know about
       clomiphene (Clomid, Serophene)?
     * What should I discuss with my healthcare provider before taking
       clomiphene (Clomid, Serophene)?
     * How should I take clomiphene (Clomid, Serophene)?
     * What happens if I miss a dose (Clomid, Serophene)?
     * What happens if I overdose (Clomid, Serophene)?
     * What should I avoid while taking clomiphene (Clomid,
       Serophene)?
     * What other drugs will affect clomiphene (Clomid, Serophene)?
     * Where can I get more information (Clomid, Serophene)?

What is clomiphene (Clomid, Serophene)?

   Clomiphene is a nonsteroidal fertility medicine. It causes the
   pituitary gland to release hormones needed to stimulate
   ovulation (the release of an egg from the ovary).

   Clomiphene is used to cause ovulation in women with certain medical
   conditions (such as polycystic ovary syndrome) that prevent
   naturally occurring ovulation.

   Clomiphene may also be used for purposes not listed in this medication
   guide.

What are the possible side effects of clomiphene (Clomid, Serophene)?

   Get emergency medical help if you have signs of an allergic reaction:
   hives; difficult breathing; swelling of your face, lips, tongue, or
   throat.

   Some women using this medicine develop a condition called ovarian
   hyperstimulation syndrome (OHSS), especially after the first treatment.
   OHSS can be a life threatening condition. Call your doctor right away
   if you have any of the following symptoms of OHSS:
     * stomach pain, bloating;
     * nausea, vomiting, diarrhea;
     * rapid weight gain, especially in your face and midsection;
     * little or no urinating; or
     * pain when you breathe, rapid heart rate, feeling short of breath
       (especially when lying down).

   Stop using clomiphene and call your doctor at once if you have:
     * pelvic pain or pressure, enlargement in your pelvic area;
     * vision problems;
     * seeing flashes of light or "floaters" in your vision;
     * increased sensitivity of your eyes to light; or
     * heavy vaginal bleeding.

   Common side effects may include:
     * flushing (warmth, redness, or tingly feeling);
     * breast pain or tenderness;
     * headache; or
     * breakthrough bleeding or spotting.

   This is not a complete list of side effects and others may occur. Call
   your doctor for medical advice about side effects. You may report side
   effects to FDA at 1-800-FDA-1088.

What is the most important information I should know about clomiphene
(Clomid, Serophene)?

   Do not use clomiphene if you are already pregnant.

   You should not use clomiphene if you have: liver disease, abnormal
   vaginal bleeding, an uncontrolled adrenal gland or thyroid
   disorder, an ovarian cyst (unrelated to polycystic ovary syndrome),
   or if you are pregnant.

   Clomid Patient Information including How Should I Take
   Infertility:Which Treatment Is Right for You?

   Infertility Treatment Slideshow
   RxList

   Take the Infertility Quiz

What should I discuss with my healthcare provider before taking clomiphene
(Clomid, Serophene)?

   You should not use clomiphene if you are allergic to it, or if you
   have:
     * abnormal vaginal bleeding;
     * an ovarian cyst that is not related to polycystic ovary
       syndrome;
     * past or present liver disease;
     * a tumor of your pituitary gland;
     * an untreated or uncontrolled problem with your thyroid or adrenal
       gland; or
     * if you are pregnant.

   To make sure clomiphene is safe for you, tell your doctor if you have:
     * endometriosis or uterine fibroids.

   Do not use clomiphene if you are already pregnant. Talk to your doctor
   if you have concerns about the possible effects of clomiphene on a new
   pregnancy.

   Clomiphene can pass into breast milk and may harm a nursing baby. This
   medicine may slow breast milk production in some women. Tell your
   doctor if you are breast-feeding a baby.

   Using clomiphene for longer than 3 treatment cycles may increase your
   risk of developing an ovarian tumor. Ask your doctor about your
   specific risk.

   Fertility treatment may increase your chance of having multiple births
   (twins, triplets). These are high-risk pregnancies both for the mother
   and the babies. Talk to your doctor if you have concerns about this
   risk.

How should I take clomiphene (Clomid, Serophene)?

   Your doctor will perform medical tests to make sure you do not have
   conditions that would prevent you from safely using clomiphene.

   Follow all directions on your prescription label. Your doctor may
   occasionally change your dose to make sure you get the best results. Do
   not take this medicine in larger or smaller amounts or for longer than
   recommended.

   Clomiphene is usually taken for 5 days, starting on the 5th day of your
   menstrual period. Follow your doctor's instructions.

   You will need to have a pelvic examination before each treatment cycle.
   You must remain under the care of a doctor while you are using
   clomiphene.

   You will most likely ovulate within 5 to 10 days after you take
   clomiphene. To improve your chance of becoming pregnant, you should
   have sexual intercourse while you are ovulating.

   Your doctor may have you take your temperature each morning and record
   your daily readings on a chart. This will help you determine when you
   can expect ovulation to occur.

   In most cases, clomiphene should not be used for more than 3 treatment
   cycles.

   If ovulation occurs but you do not get pregnant after 3 treatment
   cycles, your doctor may stop treatment and evaluate your
   infertility further.

   Store at room temperature away from moisture, heat, and light.

   Clomid Patient Information including If I Miss a Dose
   Infertility:Which Treatment Is Right for You?

   Infertility Treatment Slideshow
   RxList

   Take the Infertility Quiz

What happens if I miss a dose (Clomid, Serophene)?

   Call your doctor for instructions if you miss a dose of clomiphene.

What happens if I overdose (Clomid, Serophene)?

   Seek emergency medical attention or call the Poison Help line at
   1-800-222-1222.

What should I avoid while taking clomiphene (Clomid, Serophene)?

   This medication may cause blurred vision. Be careful if you drive or do
   anything that requires you to be alert and able to see clearly.

What other drugs will affect clomiphene (Clomid, Serophene)?

   Other drugs may interact with clomiphene, including prescription and
   over-the-counter medicines, vitamins, and herbal products. Tell each of
   your health care providers about all medicines you use now and any
   medicine you start or stop using.

Where can I get more information (Clomid, Serophene)?

   Your doctor or pharmacist can provide more information about
   clomiphene.
     __________________________________________________________________


Комментарии

Отправить комментарий

Популярные сообщения из этого блога

A healthy diet may trigger a better response to a certain kind of melanoma treatment. How?

New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In turn, a thriving gut microbiome is linked to a stronger response to an immune therapy for the aggressive skin cancer. "We found that patients eating a high-fiber diet at the start of therapy were about five times more likely to respond to the anti-PD-1 immunotherapy," said study author Christine Spencer. She's a research scientist with the Parker Institute for Cancer Immunotherapy in San Francisco. Anti-PD-1 immunotherapy helps the immune system recognize cancer cells as dangerous cells that need to be destroyed, according to the American Cancer Society (ACS). The cancer drugs Keytruda and Opdivo are examples of this type of immunotherapy. Melanoma is a type of skin cancer. It only accounts for about 1 percent of all skin cancers, but is responsible for most skin cancer deaths, the ACS says. Several recent studies have suggested that a ...
4 комментария
Далее...

American Heart Association News

On Feb. 1, 1961, twins Debbie and Donna Horst arrived at the White House to fanfare. The 6-year-olds, decked out in fancy dresses and satin sashes, found themselves surrounded by a pressing crowd and a sea of blinding flashbulbs as they made their way to see Jacqueline Kennedy. The girls -- both born with holes in their aortas -- were meeting with the first lady to kick off a national campaign to raise awareness about congenital heart defects. "There were hundreds of reporters because this was Jacqueline Kennedy' first public act as first lady," Debbie said. She recalls being startled when the reporters asked Mrs. Kennedy if they could move in closer. "It was frightening because they all jumped at us at once." The Pennsylvania twins, just a few weeks from turning 7, were among the first "Heart Fund Sweethearts" in the campaign to raise money as well as awareness. The month before, they'd met up with Micki and Patricia Gane, also of Pennsylvania...
4 комментария
Далее...

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its lead product candidate, Twirla®, an investigational low-dose combined hormonal contraceptive patch (AG200-15).  Agile resubmitted the NDA in response to a December 2017 Complete Response Letter (CRL) from the FDA, which identified deficiencies relating to (i) quality control adhesion test methods for the Twirla manufacturing process, (ii) observations identified during an inspection of a facility of our third-party manufacturer for the Twirla NDA that must be resolved, and (iii) questions on the in vivo adhesion properties of Twirla and their potential relationship to the SECURE clinical trial results. The resubmitted NDA includes the results from a...
Отправить комментарий
Далее...